The Ethics and Public Policy Center report on mifepristone has earned headlines on the right, but what does the data show?

On May 8, the Food and Drug Administration granted accelerated approval to the combination of avutometinib and defactinib for ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

The medical technology company expects the new indication to increase sales in its transcatheter aortic valve replacement ...

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

Drug approval is unequivocally the linchpin to any drug development effort and, given the role of the US market in the global ...

The FDA and CDC have also recommended pausing the use of Ixchiq in seniors 60 years and older while safety investigations are ...

No use of the drug has received FDA approval as it can result in serious ... is prescribed and dispensed or revised the drug label to warn of possible addiction," Makary said.

WE NEED TO TAKE A LOOK AT THE LABELS WHERE WE CAN AND TRY TO ... according to the FDA, whose decision approves a 2023 petition filed by New Jersey-based Innophos Inc., a mineral solutions company.

Louisiana Surgeon General Ralph Abraham backs bill to deregulate the drug ivermectin and recommends it to his own patients.